{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:48:21Z","timestamp":1792640901368,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["12967"],"award-info":[{"award-number":["12967"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["12967"],"award-info":[{"award-number":["12967"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jad.2012.03.033","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T03:05:45Z","timestamp":1334804745000},"page":"308-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":293,"title":["Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study"],"prefix":"10.1016","volume":"141","author":[{"given":"Seyed-Hesameddin","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Modabbernia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.03.033_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.20801","article-title":"Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression","volume":"28","author":"Abolfazli","year":"2011","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.jad.2012.03.033_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jad.2012.03.033_bb0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.jad.2012.03.033_bb0020","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1210\/jc.2004-1667","article-title":"Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications","volume":"90","author":"Alesci","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jad.2012.03.033_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10753-004-6055-x","article-title":"Effects of the celecoxib on the acute necrotizing pancreatitis in rats","volume":"28","author":"Alhan","year":"2004","journal-title":"Inflammation"},{"key":"10.1016\/j.jad.2012.03.033_bb0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hup.717","article-title":"IL-6 levels decrease with SSRI treatment in patients with major depression","volume":"20","author":"Basterzi","year":"2005","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.jad.2012.03.033_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S1461145705005808","article-title":"The effects of celecoxib augmentation on cytokine levels in schizophrenia","volume":"9","author":"Bresee","year":"2006","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2012.03.033_bb0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0736-0266(03)00153-0","article-title":"PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox-2 dependent pathway","volume":"22","author":"Bukata","year":"2004","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1016\/j.jad.2012.03.033_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1781(86)90040-5","article-title":"Depression, immunocompetence, and prostaglandins of the E series","volume":"17","author":"Calabrese","year":"1986","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jad.2012.03.033_bb0050","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.139.7.2414","article-title":"Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures","volume":"139","author":"Carlin","year":"1987","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.jad.2012.03.033_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jnr.10192","article-title":"Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat","volume":"68","author":"Casolini","year":"2002","journal-title":"Journal of Neuroscience Research"},{"issue":"647","key":"10.1016\/j.jad.2012.03.033_bb0060","first-page":"e7","article-title":"Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction","volume":"32","author":"Chen","year":"2010","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.joca.2011.01.018","article-title":"IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis","volume":"19","author":"Chen","year":"2011","journal-title":"Osteoarthritis and Cartilage"},{"key":"10.1016\/j.jad.2012.03.033_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.jad.2012.03.033_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","article-title":"Inflammatory markers in depression","volume":"22","author":"Dinan","year":"2009","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3109\/09553002.2010.501839","article-title":"Effect of selective COX-2 inhibitor, celecoxib on adjuvant-induced arthritis model in irradiated rats","volume":"86","author":"El-Ghazaly","year":"2010","journal-title":"International Journal of Radiation Biology"},{"key":"10.1016\/j.jad.2012.03.033_bb0090","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.4088\/JCP.8001tx13c","article-title":"Augmentation and combination strategies for complicated depression","volume":"70","author":"Fava","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02900219","article-title":"Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission","volume":"247","author":"Frommberger","year":"1997","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.jad.2012.03.033_bb0100","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archpsyc.60.10.1009","article-title":"Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults","volume":"60","author":"Glaser","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0110","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2012.03.033_bb0115","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1073\/pnas.93.10.4885","article-title":"Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2","volume":"93","author":"Hinson","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jad.2012.03.033_bb0120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.mp.4001644","article-title":"Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function","volume":"10","author":"Hu","year":"2005","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12020-006-0016-1","article-title":"Interleukin-6 production and deregulation of the hypothalamic\u2013pituitary\u2013adrenal axis in patients with major depressive disorders","volume":"30","author":"Humphreys","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.jad.2012.03.033_bb0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.1103","article-title":"A psychoneuroimmunological review on cytokines involved in antidepressant treatment response","volume":"25","author":"Janssen","year":"2010","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.jad.2012.03.033_bb0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PSY.0b013e3180313a45","article-title":"Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults","volume":"69","author":"Kiecolt-Glaser","year":"2007","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.jad.2012.03.033_bb0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0736-5748(01)00014-4","article-title":"Changes in the immune system in depression and dementia: causal or co-incidental effects?","volume":"19","author":"Leonard","year":"2001","journal-title":"International Journal of Developmental Neuroscience"},{"key":"10.1016\/j.jad.2012.03.033_bb0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archpsyc.1983.01790040059008","article-title":"CSF prostaglandin levels in depressed and schizophrenic patients","volume":"40","author":"Linnoila","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0150","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","author":"LIU","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.03.033_bb0155","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/1940-6207.CAPR-10-0317","article-title":"Celecoxib inhibits interleukin-6\/interleukin-6 receptor-induced JAK2\/STAT3 phosphorylation in human hepatocellular carcinoma cells","volume":"4","author":"Liu","year":"2011","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2012.03.033_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.9104su1c.03","article-title":"When should you move beyond first-line therapy for depression?","volume":"71","author":"McIntyre","year":"2010","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.plefa.2010.08.004","article-title":"Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover","volume":"83","author":"McNamara","year":"2010","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.jad.2012.03.033_bb0170","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.jad.2012.03.033_bb0175","first-page":"31","article-title":"COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence","volume":"11","author":"Muller","year":"2010","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1016\/j.jad.2012.03.033_bb0180","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/13543784.13.8.1033","article-title":"COX-2 inhibitors as adjunctive therapy in schizophrenia","volume":"13","author":"Muller","year":"2004","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.jad.2012.03.033_bb0185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00406-004-0478-1","article-title":"COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy","volume":"254","author":"Muller","year":"2004","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.jad.2012.03.033_bb0190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.31887\/DCNS.2009.11.3\/nmueller","article-title":"The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders \u2014 relation to drug treatment","volume":"11","author":"Muller","year":"2009","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.jad.2012.03.033_bb0200","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12640-010-9210-2","article-title":"Inflammatory biomarkers and depression","volume":"19","author":"Muller","year":"2011","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.jad.2012.03.033_bb0205","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V83.5.1408.1408","article-title":"Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes","volume":"83","author":"Musso","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jad.2012.03.033_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000107420","article-title":"Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression","volume":"14","author":"Myint","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jad.2012.03.033_bb0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.jad.2012.03.033_bb0220","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1176\/ajp.2006.163.9.1630","article-title":"Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress","volume":"163","author":"Pace","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0225","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbi.2009.07.001","article-title":"Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality","volume":"23","author":"Prather","year":"2009","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.jad.2012.03.033_bb0230","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.03.033_bb0235","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","article-title":"Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine","volume":"762","author":"Sluzewska","year":"1995","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jad.2012.03.033_bb0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1523\/JNEUROSCI.3569-08.2009","article-title":"Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment","volume":"29","author":"Song","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jad.2012.03.033_bb0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/PSY.0b013e31819082ef","article-title":"Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study","volume":"71","author":"Su","year":"2009","journal-title":"Psychosomatic Medicine"},{"key":"10.1016\/j.jad.2012.03.033_bb0250","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1902\/jop.2003.74.12.1754","article-title":"Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts","volume":"74","author":"Tipton","year":"2003","journal-title":"Journal of Periodontology"},{"key":"10.1016\/j.jad.2012.03.033_bb0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2006.07.069","article-title":"Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials","volume":"99","author":"White","year":"2007","journal-title":"The American Journal of Cardiology"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712002297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712002297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:10:33Z","timestamp":1759021833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712002297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":51,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0165032712002297"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.03.033","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}